S4E3: Myfembree for moderate-to-severe endometriosis pain: Potential for adolescents

March 2, 2022

Lindsey Carr, Editor, Jessica Y. Shim, MD

In this episode of Pap Talk, Contemporary OB/GYN® Associate Editor Lindsey Carr sat down with Jessica Shim, MD, an attending at in the Division of Gynecology, Department of Surgery, Boston Children’s Hospital; Harvard Medical School Boston, Massachusetts, to discuss Myfembree (relugolix, estradiol, and norethindrone acetate tablets; Myovant Sciences, Pfizer) and its possible approval in May 2022.

Watch the full interview here.